Skip to content

Handball-based Exercise and Type 2 Diabetes

Handball-based Exercise for People Diagnosed With Type 2 Diabetes: a Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05015946
Enrollment
10
Registered
2021-08-23
Start date
2021-09-01
Completion date
2021-12-20
Last updated
2022-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Diabetes Mellitus, Glucose Metabolism Disorder, Metabolic Diseases, Endocrine System Disease, Team Handball Training, Team Sport

Brief summary

This single-arm pilot study aims to investigate the feasibility of a handball-based intervention to people diagnosed with type 2 diabetes, including monitoring aerobic intensities and movement strategies during the intervention, and monitoring recruitment, adherence, and adverse events. Furthermore, the study aims to investigate the feasibility of a test battery including both physiological and patient-reported outcomes, and to investigate preliminary exercise effects.

Detailed description

Physical activity and exercise are known to be beneficial for increasing insulin sensitivity in skeletal muscle in healthy as well as in individuals with type 2 diabetes. But many patients who recently have been diagnosed with type-2 diabetes is often living a sedentary lifestyle and have poor adherence to physical interventions. High intensity interval training as well as team-based interventions has proven to be effectful in regulation of physiological parameters related to type 2 diabetes. The aim of this study is to investigate the feasibility of a handball-based intervention to people diagnosed with type 2 diabetes

Interventions

BEHAVIORALSmall-sided team handball training

60 minutes small-sided team handball training. Initial 20 minutes of warm-up including exercises for strength, aerobic, balance, coordination, and mobility. Hereafter 20 minutes of handball specific exercises including dribbling, running and shooting. Final 20 minutes of small-sided handball matches.

Sponsors

Danish Handball Federation
CollaboratorUNKNOWN
The Danish Diabetes Association
CollaboratorOTHER
Research Unit for General Practice in Aalborg
CollaboratorOTHER
University College of Northern Denmark
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

No masking

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with type 2 diabetes * Understands and speaks danish

Exclusion criteria

* If General Practitioner do not recommend participation in the intervention

Design outcomes

Primary

MeasureTime frameDescription
Concentration of Hemoglobin A1c (HbA1c) (mmol/mol)change from baseline to 12 weeksHbA1c measured with HemoCue HbA1c 501
Peak oxygen uptake (VO2peak)change from baseline to 12 weeksPeak oxygen uptake measured with incremental cycling test
Health related quality of life (HRQoL)change from baseline to 12 weeksHealth related quality of life measured with the danish version of Short Form 36 (SF-36)

Secondary

MeasureTime frameDescription
Lean body mass (kg)change from baseline to 12 weeksLean body mass in kg measured with Tanita MC-180MA, Tokyo, Japan
Visceral fat (hip/waist ratio)change from baseline to 12 weeksVisceral adipose tissue measured with hip (widest part of the hip) and waist (2.5 cm above the navel) ratio.
Blood pressure and resting pulschange from baseline to 12 weeksBlood pressure and resting puls measured with an automatic upperarm blood pressure monitor
Concentration of Cholesterolchange from baseline to 12 weeksTotal cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL) measured with Accutrend Plus Cholesterol Meter
Self-care behaviorchange from baseline to 12 weeksSelf-care behavior measured with diabetes Intention, Attitude, and Behavior Questionnaire (DIAB-Q)
Physical activity levelschange from baseline to 12 weeksPhysical activity scale (PAS)
Aerobic intensity and movement patternsmeasured during intervention in week 2,3,6,7,10 and 11.Aerobic intensities (percent of maximal heart rate) measured with pulse monitor, and movement patterns (Metabolic Equivalent of Task (MET)) measured with accelerometer.
Aerobic performance test (aerobic endurance)change from baseline to 12 weeksAerobic endurance measured with Intermittent Recovery Test Level 1
Body mass index (BMI)change from baseline to 12 weeksBody mass index measured by kg/M2
Body fat mass (kg)change from baseline to 12 weeksTotal body fat in kg measured with Tanita MC-180MA, Tokyo, Japan

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026